Elan Pharmaceuticals, Inc. (Ireland)

Homepage: elan.com

Alternate names: Elan Corp. PLC, Elan Corporation PLC, Elan Pharma, Elan Pharmaceuticals, Elan Pharmaceuticals, Inc., Élan

ROR: 02s1xv184

OpenAlex ID: I4405267435

Core outcome measures for chronic pain clinical trials: IMMPACT recommendations

2004 · Robert H. Dworkin, Dennis C. Turk, et al. · Pain · 3,724

Core outcome domains for chronic pain clinical trials: IMMPACT recommendations

2003 · Dennis C Turk, Robert H Dworkin, et al. · Pain · 3,496

Forecasting the global burden of Alzheimer's disease

2007 · Ron Brookmeyer, Elizabeth Johnson, et al. · Alzheimer s & Dementia · 3,357

Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1999 · Dale Schenk, Robin Barbour, et al. · Nature · 3,161

Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

2000 · Frédérique Bard, Catherine Cannon, et al. · Nature Medicine · 2,014

High-Level Neuronal Expression of Aβ1–42in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation

2000 · Lennart Mucke, Eliezer Masliah, et al. · Journal of Neuroscience · 1,858

PDF

Purification and cloning of amyloid precursor protein β-secretase from human brain

1999 · Sukanto Sinha, John P. Anderson, et al. · Nature · 1,612

Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease

1999 · Lih-Fen Lue, Yu-Min Kuo, et al. · American Journal Of Pathology · 1,531

PDF

Phosphorylation of Ser-129 Is the Dominant Pathological Modification of α-Synuclein in Familial and Sporadic Lewy Body Disease

2006 · John P. Anderson, Donald E. Walker, et al. · Journal of Biological Chemistry · 1,416

Nanosizing: a formulation approach for poorly-water-soluble compounds

2003 · Elaine Merisko-Liversidge, Gary G Liversidge, et al. · European Journal of Pharmaceutical Sciences · 1,263

Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease

2003 · P. Giannakopoulos, F. R. Herrmann, et al. · Neurology · 1,118

Alzheimer's Disease: Molecular Understanding Predicts Amyloid-Based Therapeutics

2003 · Dennis J. Selkoe, Dale Schenk · The Annual Review of Pharmacology and Toxicology · 818

Natalizumab for Active Crohn's Disease

2003 · Subrata Ghosh, Eran Goldin, et al. · New England Journal of Medicine · 812

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

2009 · S. Salloway, R. Sperling, et al. · Neurology · 750

PDF

A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease

2000 · Guiquan Chen, Karen S. Chen, et al. · Nature · 741

11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

2010 · Juha O Rinne, David J Brooks, et al. · The Lancet Neurology · 701

Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease

2009 · Joseph L. Price, Daniel W. McKeel, et al. · Neurobiology of Aging · 660

Intrathecal Ziconotide in the Treatment of Refractory Pain in Patients With Cancer or AIDS

2004 · Peter S. Staats, Thomas Yearwood, et al. · JAMA · 654

Amyloid precursor protein processing and Aβ 42 deposition in a transgenic mouse model of Alzheimer disease

1997 · K. Johnson-Wood, M. Lee, et al. · Proceedings of the National Academy of Sciences · 646

Natalizumab for the Treatment of Active Crohn’s Disease: Results of the ENCORE Trial

2007 · Stephan R. Targan, Brian G. Feagan, et al. · Gastroenterology · 614

Statistical Methods for the Analysis of Repeated Measurements

2002 · Charles S. Davis · Springer texts in statistics · 584

Red Blood Cells Are the Major Source of Alpha-Synuclein in Blood

2008 · Robin Barbour, Kristin Kling, et al. · Neurodegenerative Diseases · 527

Liposome‐encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first‐line therapy of metastatic breast carcinoma

2001 · Lyndsay Harris, Gerald Batist, et al. · Cancer · 512

PDF

Imaging of amyloid-β deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy

2001 · Brian J. Bacskai, Stephen T. Kajdasz, et al. · Nature Medicine · 450

High Cerebrospinal Fluid Tau and Low Amyloid β42 Levels in the Clinical Diagnosis of Alzheimer Disease and Relation to Apolipoprotein E Genotype

1998 · D. Galasko, L. Chang, et al. · Archives of Neurology · 443

Works count: 368

Citation count: 323,200